All the Active Ingredient Drugs
Corticosteroid, Vitamin D Analogue. Betamethasone (as dipropionate) 0.5 mg/g, Calcipotriol (as monohydrate) 50 mcg/g. ALUMINIUM CAN:60 g.
Enstilar foam should be applied to the affected area once dly. The recom. tmt. period is 4 wks. The dly. max. dose should not exceed 15 g, i.e. one 60 g can should last for at least 4 d. 15 g corresponds to the amount admin. from the can if the actuator is fully depressed for approx. one minute. A two-second application delivers approx. 0.5 g. As a guide, 0.5 g of foam should cover an area of skin roughly correspond. to the surface area of an adult hand. Concomit. use with other topic. products contain. calcipotriol in addition to Enstilar: the total dose of all calcipotriol contain. products should not exceed 15 g/d. The total bdy. surf. area treated should not exceed 30%.
Ren. / hep. impair. The safety and efficacy in pts. with severe renal insuffic. or severe Hep. disord. have not been evaluated.
Ped. population:The safety and efficacy in child. below 18 yrs. have not been establish. Enstilar is not indic. for child<18 yrs. of age.
Topical tmt. of psoriasis vulgaris in adults.
C/I: Hypersens.
Pts. with erythrodermic and pustular psorias.
Pts. with known calcium metabolism disord.
Corticosteroid, Vitamin D Analog. Calcipotriol (as monohydrate) 150 mcg/g, Betamethasone (as dipropionate) 0.5 mg/g. Gel: 30/60 g
To be applied to affected areas once/d. Tmt. period is 4 weeks for scalp areas and 8 weeks for “non-scalp” areas. If it is necessary to cont. or restart after this period, do so after medical review and under regular med. supervision.
When using calcipotriol cont. prod., the max. daily dose should not exceed 15 g. Body surface area treated with calcipotriol cont. prod. should not exceed 30%.
Tmt. of psoriasis of the scalp and tmt. of mild to moder. psoriasis vulgaris of other body areas in adults 18 years of age and older.
C/I: * Hypersens/ known disorders of calcium metabolism/
Erythrodermic, exfoliative and pustular psoriasis/ Due to the cont. of corticosteroid, contraindicated in:Viral (e.g. herpes or varicella) lesions of the skin, fungal or bacterial skin infect., parasitic infect., skin manifest. in relation to tuberculosis, perioral dermatitis, atrophic skin, striae atrophicae, fragility of skin veins, ichthyosis, acne vulgaris, acne rosacea, rosacea, ulcers, wounds.
